Augusto Villanueva's Avatar

Augusto Villanueva

@augustonyc.bsky.social

Hepatologist focused on liver cancer. Medical Director, Liver Cancer Program at NYU Langone. Tweets are mine. Like/retweet ≠ endorsement

463 Followers  |  86 Following  |  1 Posts  |  Joined: 12.11.2024  |  1.5028

Latest posts by augustonyc.bsky.social on Bluesky

Thrilled to share that I’ve joined NYU Langone as Medical Director of the Liver Cancer Program. Grateful for the opportunity to lead an incredible team focused on pushing the boundaries of liver cancer care and research. Big things ahead.

21.05.2025 19:55 — 👍 5    🔁 0    💬 1    📌 0
The figure shows the percentage of patients with fibrosis stage 2 or 3 who had resolution of steatohepatitis with no worsening of liver fibrosis (Panel A) and reduction in liver fibrosis with no worsening of steatohepatitis (Panel B) after 72 weeks, with the estimated difference expressed in percentage points.

The figure shows the percentage of patients with fibrosis stage 2 or 3 who had resolution of steatohepatitis with no worsening of liver fibrosis (Panel A) and reduction in liver fibrosis with no worsening of steatohepatitis (Panel B) after 72 weeks, with the estimated difference expressed in percentage points.

In this interim analysis of a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly semaglutide improved liver histologic results at 72 weeks. Full ESSENCE trial results: nej.md/3EVFAFM

#MedSky #EndoSky #GastroSky

30.04.2025 21:10 — 👍 19    🔁 9    💬 0    📌 1
Post image Post image Post image

Every year I feel so fortunate to be part of this #LiverCancer community with these amazing friends who are true leaders sharing a common goal!! Amongst the beautiful chaos that is life, it’s important to find your passion and your people 💚. That’s a wrap @hcclive.bsky.social

22.02.2025 23:09 — 👍 6    🔁 4    💬 0    📌 0
Preview
AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the ...

🚨 AGA New Guideline Alert Link🚨
▶️ AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
I’ll break down its FIVE recommendations over the next 12 posts 🧵 👇
#AGA #GI #HBV

www.gastrojournal.org/article/S001...

23.01.2025 16:55 — 👍 2    🔁 2    💬 1    📌 0
Post image Post image

Recap of 2024 for #LiverSky

📅FEBRUARY was omics month:
@jhepatology.bsky.social review on opportunities & barriers for omics as biomarkers

💪Powerful technologies which we are only now starting to explore in clinical care

🔗https://www.journal-of-hepatology.eu/article/S0168-8278(24)00219-8/fulltext

14.01.2025 15:45 — 👍 8    🔁 1    💬 0    📌 0
Post image

It me

08.12.2024 16:35 — 👍 7359    🔁 1050    💬 143    📌 61
Post image

Do conversations about prognosis (defined as "conversation with your hepatologist about the likely outcome of your liver disease over time") cause patients w/ cirrhosis to lose hope?

Simple answer: No

Work led by🌟@donlan_john in CGH @amergastroassn.bsky.social https://buff.ly/4i1R6OM #LiverSky

24.11.2024 14:57 — 👍 27    🔁 9    💬 3    📌 0

We are on our second starter pack for GI / Hepatology
Part 1: go.bsky.app/8Pho2tp
Part 2: go.bsky.app/VGyLKjR

#medsky #GIsky #LiverSky

15.11.2024 15:17 — 👍 100    🔁 32    💬 23    📌 11

Ponni Perumalswami gave such a beautiful talk on management of alcohol-related liver disease at #TLM24 post-graduate course.

15.11.2024 17:31 — 👍 9    🔁 1    💬 1    📌 0

@augustonyc is following 20 prominent accounts